Abstract
Bone cancer pain is a multifactorial process with many potential targets for therapeutic intervention. As pain is the most common presenting symptom in patients with skeletal metastases and is directly proportional to the patient's quality of life, clinical improvements in the treatment of bone cancer pain are of the utmost importance. Research targeting pain-related cytokines, anti-osteoclastic medications, and ion channels have shown significant clinical progress in the treatment of cancer-related bone pain. With continued efforts into these and other therapeutic strategies, we hope to continue to improve the quality of life of those patients suffering with bone cancer pain.
| Original language | English (US) |
|---|---|
| Title of host publication | Bone Cancer |
| Subtitle of host publication | Primary Bone Cancers and Bone Metastases: Second Edition |
| Publisher | Elsevier Inc. |
| Pages | 571-577 |
| Number of pages | 7 |
| ISBN (Electronic) | 9780124167285 |
| ISBN (Print) | 9780124167216 |
| DOIs | |
| State | Published - 2015 |
Bibliographical note
Publisher Copyright:© 2015 Elsevier Inc. All rights reserved..
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Bone cancer
- Pain
- Skeletal mestastasis
Fingerprint
Dive into the research topics of 'Mechanisms and management of bone cancer pain'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS